Photoallergic contact dermatitis due to treatment of pulmonary fibrosis with pirfenidone
暂无分享,去创建一个
A. Wollenberg | T. Ruzicka | M. Reinholz | B. Przybilla | F. Ruëff | J. Schauber | W. Wulffen | R. Varga | I. Goldscheider | I. Eder | A. Schaumann
[1] T. Maher,et al. Current and novel drug therapies for idiopathic pulmonary fibrosis , 2012, Drug design, development and therapy.
[2] S. Sahn,et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials , 2011, The Lancet.
[3] D. Fairclough,et al. Pirfenidone in idiopathic pulmonary fibrosis , 2010, European Respiratory Journal.
[4] G. Raghu,et al. Pirfenidone in idiopathic pulmonary fibrosis , 2009, European Respiratory Journal.
[5] W. Gahl,et al. Alveolar macrophage dysregulation in Hermansky-Pudlak syndrome type 1. , 2009, American journal of respiratory and critical care medicine.
[6] S. Kudoh,et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2005, American journal of respiratory and critical care medicine.
[7] H. Oku,et al. Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis , 2004, European Respiratory Journal.
[8] G. Raghu,et al. Treatment of Idiopathic Pulmonary Fibrosis with a New Antifibrotic Agent , Pirfenidone Results of a Prospective , Open-label Phase II Study , 1999 .